Filter
166
Text search:
Anti-Tuberculosis
medicines
Featured
28
54
Language
Document type
129
14
12
6
2
2
1
Countries / Regions
9
8
7
6
6
6
5
5
4
4
4
4
3
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
64
28
5
5
3
2
2
Toolboxes
86
9
8
6
4
3
2
2
1
1
An in-depth analysis of the health-seeking behaviour of patients and health system response in seven countries of the Eastern Mediterranean Region
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Interim policy guidance
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar
...
Policy and Manual
HIV & AIDS Treatment in Practice No.202
National Tuberclosis and
Leprosy Programme (NTLP)
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim
...
